Bivatuzumab (Anti-CD44v6)Bivatuzumab (Anti-CD44v6)
Move your mouse over image or click to enlarge

Bivatuzumab (Anti-CD44v6)

Bivatuzumab (Anti-CD44v6) is a humanized monoclonal antibody targeting against CD44v6 that could acts as a sarcoma target for CAR-redirected CIK cells. MW:145.5 KD.
Cat# Size Price Qty Buy
A2555-1mg*25 1mg*25
£1,941.00
A2555-1mg*5 1mg*5
£647.00
A2555-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2555

Related Documents